Published in Dig Dis Sci on April 01, 2009
Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf (2010) 1.56
Statins and colorectal cancer. Clin Gastroenterol Hepatol (2012) 1.36
Anticancer activity of the cholesterol exporter ABCA1 gene. Cell Rep (2012) 1.14
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst (2011) 1.06
The relationship between patient physiology, the systemic inflammatory response and survival in patients undergoing curative resection of colorectal cancer. Br J Cancer (2010) 1.02
Statin use and association with colorectal cancer survival and risk: case control study with prescription data linkage. BMC Cancer (2012) 0.91
Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis. PLoS One (2014) 0.90
Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.84
Metabolic syndrome contributes to an increased recurrence risk of non-metastatic colorectal cancer. Oncotarget (2015) 0.81
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer. Br J Cancer (2015) 0.80
Relationship between the use of statins and patient survival in colorectal cancer: a systematic review and meta-analysis. PLoS One (2015) 0.80
Statin use is not associated with improved progression free survival in cetuximab treated KRAS mutant metastatic colorectal cancer patients: results from the CAIRO2 study. PLoS One (2014) 0.80
Chemopreventive drugs: mechanisms via inhibition of cancer stem cells in colorectal cancer. World J Gastroenterol (2014) 0.77
Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy. Br J Cancer (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Statins and the risk of colorectal cancer. N Engl J Med (2005) 6.86
The risk of cancer in users of statins. J Clin Oncol (2004) 3.01
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia (2002) 2.89
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res (2002) 1.79
Potential antitumor effects of statins (Review). Int J Oncol (2003) 1.54
The role of statins in cancer therapy. Oncologist (2006) 1.46
Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol (2007) 1.45
Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. Cancer Res (2001) 1.35
Statin use and risk of colorectal cancer. J Natl Cancer Inst (2007) 1.29
Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology (1999) 1.16
Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Oncology (2000) 0.89
Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol (1996) 0.89
Chemoprevention by pravastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, of N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn J Cancer Res (1996) 0.84
Following positive epidemiologic studies, statins to enter clinical trials for cancer prevention. J Natl Cancer Inst (2005) 0.83
Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens. Int J Oncol (2002) 0.83
Drug insight: statins and gastrointestinal cancer. Nat Clin Pract Gastroenterol Hepatol (2006) 0.78
Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med (2009) 10.91
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology (2011) 3.44
Cutaneous manifestations of gastrointestinal disease: part I. J Am Acad Dermatol (2013) 2.58
Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 patients from 65 studies. JACC Cardiovasc Interv (2013) 2.54
Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality. Gastrointest Endosc (2009) 2.44
Cutaneous manifestations of gastrointestinal disease: part II. J Am Acad Dermatol (2013) 2.38
Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol (2003) 2.21
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology (2009) 2.05
Acid has antiproliferative effects in nonneoplastic Barrett's epithelial cells. Am J Gastroenterol (2007) 1.92
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol (2009) 1.80
Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. Gastroenterology (2009) 1.72
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol (2005) 1.72
Prone positioning of obese patients for colonoscopy results in shortened cecal intubation times: a randomized trial. Dig Dis Sci (2012) 1.62
A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone (2005) 1.59
The rate of post-polypectomy bleeding for patients on uninterrupted clopidogrel therapy during elective colonoscopy is acceptably low. Dig Dis Sci (2011) 1.52
A previous cholecystectomy increases the risk of developing advanced adenomas of the colon. South Med J (2009) 1.49
Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One (2012) 1.43
Impact of a Disposable Sterile Radiation Shield on Operator Radiation Exposure During Percutaneous Coronary Intervention of Chronic Total Occlusions. J Invasive Cardiol (2015) 1.40
Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci (2008) 1.38
Esophagitis dissecans superficialis ("sloughing esophagitis"): a clinicopathologic study of 12 cases. Am J Surg Pathol (2009) 1.37
Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach. CA Cancer J Clin (2005) 1.22
Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut (2009) 1.20
Tissue remodeling in eosinophilic esophagitis. Am J Physiol Gastrointest Liver Physiol (2012) 1.20
Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. Gastroenterology (2010) 1.18
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. Am J Physiol Gastrointest Liver Physiol (2011) 1.17
In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. Cancer Res (2009) 1.16
Hallmarks of cancer progression in Barrett's oesophagus. Lancet (2002) 1.13
The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis. J Rheumatol (2007) 1.12
The prophylactic placement of hemoclips to prevent delayed post-polypectomy bleeding: an unnecessary practice? A case control study. Dig Dis Sci (2014) 1.12
Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy. Clin Gastroenterol Hepatol (2013) 1.12
Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol (2008) 1.10
Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. Am J Physiol Gastrointest Liver Physiol (2005) 1.08
Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway. Cancer Res (2009) 1.07
Current strategies in the management of intra-abdominal abscesses in Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.06
NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-kappaB in Barrett's esophageal adenocarcinoma cells. J Biol Chem (2007) 1.06
Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.04
Surgical bypass versus endoscopic stenting for malignant gastroduodenal obstruction: a decision analysis. Dig Dis Sci (2006) 1.04
Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus. Am J Gastroenterol (2005) 1.03
Information assimilation and distribution challenges and goals for real and virtual journals. J Clin Gastroenterol (2005) 1.02
Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. Am J Physiol Gastrointest Liver Physiol (2010) 0.98
Long-term use of angiotensin converting enzyme inhibitors is associated with decreased incidence of advanced adenomatous colon polyps. J Clin Gastroenterol (2011) 0.97
In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway. Cancer Res (2007) 0.95
Malignant transformation of non-neoplastic Barrett's epithelial cells through well-defined genetic manipulations. PLoS One (2010) 0.95
Obesity is associated with an increased prevalence of advanced adenomatous colon polyps in a male veteran population. Dig Dis Sci (2009) 0.95
Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. J Clin Invest (2014) 0.92
Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells. Am J Physiol Gastrointest Liver Physiol (2010) 0.92
Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91
Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. Am J Physiol Gastrointest Liver Physiol (2007) 0.90
2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of gastroesophageal reflux disease. J Gastrointest Surg (2014) 0.88
All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells. Am J Physiol Gastrointest Liver Physiol (2006) 0.88
Stent loss and retrieval during percutaneous coronary interventions: a systematic review and meta-analysis. J Invasive Cardiol (2013) 0.87
The long-term use of statins is associated with a decreased incidence of adenomatous colon polyps. Digestion (2009) 0.87
Development, calibration, and validation of a U.S. white male population-based simulation model of esophageal adenocarcinoma. PLoS One (2010) 0.87
Clinical implications of histologic abnormalities in colonic biopsy specimens from patients with ulcerative colitis in clinical remission. Inflamm Bowel Dis (2013) 0.86
Current investigational drugs in psoriasis. Expert Opin Investig Drugs (2012) 0.86
Multilayered epithelium in mucosal biopsy specimens from the gastroesophageal junction region is a histologic marker of gastroesophageal reflux disease. Am J Surg Pathol (2009) 0.85
Safety and efficacy of metallic stents in the management of colorectal obstruction. JSLS (2005) 0.84
Reduction in low-density lipoprotein cholesterol levels during statin therapy is associated with a reduced incidence of advanced colon polyps. Am J Med Sci (2009) 0.83
Blue Nevus-Like Metastasis of a Cutaneous Melanoma Identified by Fluorescence In Situ Hybridization. Am J Dermatopathol (2016) 0.83
Optical coherence tomography evaluation of drug-eluting stents: a systematic review. Catheter Cardiovasc Interv (2012) 0.82
GERD evaluation: time for a new paradigm? J Clin Gastroenterol (2007) 0.81
Increase in body size is associated with an increased incidence of advanced adenomatous colon polyps in male veteran patients. Digestion (2011) 0.81
Emerging topical treatments for psoriasis. Expert Opin Emerg Drugs (2013) 0.81
GERD 2003 -- a consensus on the way ahead. Digestion (2003) 0.79
A case of duodenal Entamoeba histolytica. Gastrointest Endosc (2009) 0.77
Biological therapies for psoriasis. Expert Opin Biol Ther (2013) 0.77
Barrett's esophagus: chemoprevention. Gastrointest Endosc Clin N Am (2003) 0.76
Ustekinumab treatment for psoriasis in 119 patients maintained on therapy for a minimum of one year: a review. J Drugs Dermatol (2014) 0.76
Thermal ablation of Barrett's esophagus: a heated debate. Am J Gastroenterol (2006) 0.75
Widespread dermal ulcerations and bullae. Proc (Bayl Univ Med Cent) (2012) 0.75
Secondary syphilis and HIV. Proc (Bayl Univ Med Cent) (2012) 0.75
Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn's Disease in Remission. J Clin Gastroenterol (2017) 0.75
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009. J Drugs Dermatol (2014) 0.75
Reproducibility of near-infrared spectroscopy for the detection of lipid core coronary plaques and observed changes after coronary stent implantation. Catheter Cardiovasc Interv (2010) 0.75
The simple function of the esophagus belies the organ’s complexity. Editorial. Curr Opin Gastroenterol (2013) 0.75
Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol (2005) 0.75
Biologic agent use varies inversely with age at diagnosis in Crohn's disease. Dig Dis Sci (2010) 0.75
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis: Insights from the Atherosclerosis Lesion Progression Intervention Using Niacin Extended Release in Saphenous Vein Grafts (ALPINE-SVG) Pilot Trial. J Invasive Cardiol (2015) 0.75
Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest That Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis. J Clin Gastroenterol (2017) 0.75
Myocardial Infarction Related to Trauma. Rev Cardiovasc Med (2015) 0.75
Through-the-scope, wire-guided esophageal dilation for the treatment of food impaction. Dig Dis Sci (2008) 0.75
Menopausal Vasomotor Symptoms (MVS) survey for assessment of hot flashes. J Womens Health (Larchmt) (2006) 0.75